John W. Madsen

932 total citations
11 papers, 791 citations indexed

About

John W. Madsen is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, John W. Madsen has authored 11 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Physiology. Recurrent topics in John W. Madsen's work include Erythrocyte Function and Pathophysiology (3 papers), Neonatal Health and Biochemistry (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). John W. Madsen is often cited by papers focused on Erythrocyte Function and Pathophysiology (3 papers), Neonatal Health and Biochemistry (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). John W. Madsen collaborates with scholars based in United States and Australia. John W. Madsen's co-authors include Yutaka Tanaka, A. J. Schroit, B. Kim Lee Sim, A H Fortier, Hong Liang, Michael S. O’Reilly, Alan J. Schroit, Robert S. Schwartz, Anne C. Rybicki and Ronald L. Nagel and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Diabetes.

In The Last Decade

John W. Madsen

11 papers receiving 747 citations

Peers

Countries citing papers authored by John W. Madsen

Since Specialization

Citations

This map shows the geographic impact of John W. Madsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Madsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Madsen more than expected).

Fields of papers citing papers by John W. Madsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Madsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Madsen. The network helps show where John W. Madsen may publish in the future.

Co-authorship network of co-authors of John W. Madsen

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Madsen. A scholar is included among the top collaborators of John W. Madsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Madsen. John W. Madsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Large-Scale Purification of Recombinant Human Angiostatin 2000 ·Protein Expression and Purification ·(unknown), R.V. Boucher, (unknown), Renee J. Boerner, G. Koch, John W. Madsen, Davida K. Grella, B. Kim Lee Sim, Jeffrey L. Schrimsher	21
2	Zinc ligand-disrupted recombinant human Endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile 1999 ·Angiogenesis ·B. Kim Lee Sim, William E. Fogler, (unknown), Hong Liang, John W. Madsen, (unknown), Michael S. O’Reilly, Joseph E. Tomaszewski, A H Fortier	62
3	Synthesis and Enantiomeric Separation of 2-Phthalimidino-glutaric Acid Analogues: Potent Inhibitors of Tumor Metastasis 1999 ·Journal of Medicinal Chemistry ·Jamshed H. Shah, Glenn M. Swartz, Adonia E. Papathanassiu, Anthony M. Treston, William E. Fogler, John W. Madsen, Shawn J. Green	23
4	A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. 1997 ·PubMed ·B. Kim Lee Sim, Michael S. O’Reilly, Hong Liang, A H Fortier, (unknown), John W. Madsen, (unknown), Carol A. Nacy	166
5	Liposomal Vaccines 1995 ·Advances in experimental medicine and biology ·Shawn J. Green, A H Fortier, J.W. Dijkstra, John W. Madsen, Glenn M. Swartz, Leo Einck, (unknown), Carol A. Nacy	6
6	Analysis of anticholesterol antibodies using hydrophobic membranes 1995 ·Journal of Immunological Methods ·(unknown), Glenn M. Swartz, J.W. Dijkstra, John W. Madsen, (unknown), Shawn J. Green	9
7	Oxidation of Spectrin and Deformability Defects in Diabetic Erythrocytes 1991 ·Diabetes ·Robert S. Schwartz, John W. Madsen, Anne C. Rybicki, Ronald L. Nagel	94
8	Radioiodinated, photoactivatable phosphatidylcholine and phosphatidylserine: transfer properties and differential photoreactive interaction with human erythrocyte membrane proteins 1987 ·Biochemistry ·Alan J. Schroit, John W. Madsen, Arnold E. Ruoho	62
9	In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. 1985 ·Journal of Biological Chemistry ·A. J. Schroit, John W. Madsen, Yutaka Tanaka	291
10	Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases. 1984 ·PubMed ·James E. Talmadge, (unknown), John W. Madsen, Isaiah J. Fidler	43
11	Synthesis and properties of radioiodinated phospholipid analogs that spontaneously undergo vesicle-vesicle and vesicle-cell transfer 1983 ·Biochemistry ·Alan J. Schroit, John W. Madsen	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact